Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
No indication information available.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.